Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest biopharmaceutical Stories

2014-02-12 08:28:14

"Your Journey. Our Mission.(TM)" communicates company's new brand promise BOSTON, Feb. 12, 2014 /PRNewswire/ -- As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science...

2014-02-11 23:31:22

Gallus BioPharmaceuticals, LLC, a premier pure-play biologics contract manufacturing organization announces the appointment of Claudette Kile as Vice President of Quality & Regulatory. St. Louis, MO (PRWEB) February 11, 2014 Gallus BioPharmaceuticals, LLC (Gallus), a premier pure-play biologics contract manufacturing organization (CMO) announces the appointment of Claudette Kile as Vice President of Quality & Regulatory. This addition to the highly experienced Gallus leadership...

2014-02-11 08:33:33

AMSTERDAM, February 11, 2014 /PRNewswire/ -- - SynCo's live microbial track record, GMP scale-up and commercial manufacturing capabilities will facilitate the advancement of Advaxis' ADXS-HPV program - SynCo Bio Partners B.V. [http://www.syncobiopartners.com ], a leading services provider for GMP manufacturing of live microbial vaccines and biotherapeutics today announces that they have entered into a long term manufacturing collaboration with Advaxis, Inc....

2014-02-06 16:27:50

MONROVIA, Calif., Feb. 6, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that Bassil Dahiyat, Ph.D., Chief Executive Officer, will present at the 2014 Leerink Global Healthcare Conference on Thursday, February 13, 2014 at 2:15 p.m. EST at the Waldorf Astoria Hotel in New York, NY. A live audio...

2014-02-05 12:29:08

LA JOLLA, Calif., Feb. 5, 2014 /PRNewswire/ -- Avidity NanoMedicines LLC, a biopharmaceutical company pioneering a breakthrough approach to the targeted delivery of nucleic acid-based medicines, announced today that Arthur A. Levin, Ph.D., has joined the company as Executive Vice President of Research and Development. In this role, Dr. Levin will be responsible for leading Avidity's research and development organization and overseeing advancement of its drug pipeline. "Art brings an...

2014-02-05 08:28:25

CHESTERBROOK, Pa., Feb. 5, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Leerink Swann Global Healthcare Conference to be held February 11-13, 2014 at the Waldorf Astoria Hotel in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to participate in a discussion about the Company at 10:40...

2014-02-04 08:34:28

-Mr. Szekeres Brings Extensive Strategic and Transactional Deal Experience- LA JOLLA, Calif., Feb. 4, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the addition of David Szekeres to its executive management team as Chief Business Officer and General Counsel. Most recently, Mr. Szekeres served as Deputy General Counsel, Chief M&A Counsel...

2014-02-03 08:28:37

Healthcare Executive Brings Expertise in New Product Commercialization, Licensing, and Mergers and Acquisitions FORT COLLINS, Colo., Feb. 3, 2014 /PRNewswire/ -- CHD Bioscience, Inc. a development-stage biopharmaceutical company focused on the discovery, development and commercialization of novel products active against multi-resistant pathogens, is pleased to announce the appointment of Catherine Angell Sohn, Doctor of Pharmacy (Pharm.D.), to its Board of Directors. Dr. Sohn will...

2014-02-03 08:26:54

CHESTERBROOK, Pa., Feb. 3, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the BIO CEO & Investor Conference to be held February 10-11, 2014 at the Waldorf Astoria Hotel in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 9...

2014-01-31 23:02:54

Recognizing the Outstanding People, Organizations and Technologies That Have Significantly Changed, Impacted, and Advanced the Efficiency of Biotherapeutic Development and Manufacturing; Awards Nominations Open Through June, 2014 New York, NY (PRWEB) January 31, 2014 BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals, vaccines, cell therapies and therapeutics,...